Robert J. Greenberg, CHIEF EXECUTIVE OFFICER at SECOND SIGHT MEDICAL PRODUCTS INC (EYES), sold 200,753 shares at $13.96 ($2.8M) on 2015-06-02, disclosed to the SEC on 2015-06-04.
Scheduled sale ($2.8M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.96 | 26,586 | $371K | 13.2% |
| 2 | $13.96 | 78,153 | $1.1M | 38.7% |
| 3 | $14.12 | 24,167 | $341K | 12.1% |
| 4 | $14.12 | 71,847 | $1.0M | 36.0% |
| Total | $14.04 avg | 200,753 | $2.8M | 100% |
| Filing → |
| EYES | SELL | 2016-06-06 | $35K | — | Filing → |
| EYES | SELL | 2016-04-20 | $43K | — | Filing → |
| EYES | SELL | 2015-12-09 | $95K | — | Filing → |